CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them

Conventional therapies for acute myeloid leukemia (AML) are characterized by high rates of relapse, severe toxicities, and poor overall survival rates. Thus, the development of new therapeutic strategies is crucial for improving the survival and quality of life of AML patients. CD19-directed chimeri...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanhooren, Jolien, Dobbelaere, Rani, Derpoorter, Charlotte, Deneweth, Larissa, Van Camp, Laurens, Uyttebroeck, Anne, De Moerloose, Barbara, Lammens, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479376/
https://www.ncbi.nlm.nih.gov/pubmed/37674860
http://dx.doi.org/10.1097/HS9.0000000000000937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479376/
https://www.ncbi.nlm.nih.gov/pubmed/37674860
http://dx.doi.org/10.1097/HS9.0000000000000937

Ejemplares similares